The drug label has a [[black box warning]] that the drug cause may cause serious psychiatric and behavioral changes; it may cause homicidal or suicidal thoughts.<ref name=LabelFDA/>  Other side effects have included dizziness, somnolence, vertigo, aggression, anger, [[ataxia|loss of coordination]], blurred vision, irritability, and [[dysarthria|slurred speech]].<ref name=LabelFDA/> Permapanel reduced the effectiveness of levonorgestrel [[oral contraceptives]] by about 40%.<ref name=LabelFDA/>   Women who may get pregnant should not take it as studies in animals show it may harm a fetus.<ref name=EMAreport>EMA  [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf Summary of Product Characteristics].  {{cite web | url =http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002434/human_med_001572.jsp&mid=WC0b01ac058001d124 | title =Index pagel}}</ref>  Perampanel is liable to be abused; very high doses produced euphoria responses similar to [[ketamine]].<ref name=LabelFDA/> It is designated as a Schedule III [[controlled substance]] by the [[Drug Enforcement Administration]].<ref name=LabelFDA/>

 


 
As of August 2016 perampanel had been studied and development discontinued in migraine, multiple sclerosis, neuropathic pain, and Parkinson's disease.<ref name=AdisInsight>{{cite web|title=Perampanel|url=http://adisinsight.springer.com/drugs/800015670|publisher=AdisInsight|accessdate=August 29, 2016}}</ref>

 

